IOTOD 2020

The 18th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place as a virtual event on the 24–25 September 2020.

The 2020 IOTOD Scientific Committee led an engaging two-day meeting, featuring international field experts speaking on multiple and emerging topics, such as: opioid analgesic dependence (OAD) and chronic pain; opioid substitution therapy adherence and the real significance; destigmatising drug use in key populations; the experience so far with long-acting buprenorphine formulations (and their use during COVID-19); different stakeholder perspectives surrounding drug use; and best approaches to address HCV/HBV in PWIDs. The webcasts from this conference will be available to view on the IOTOD 2021 conference platform once you have registered for the event.


Professor John Strang

Director, National Addiction Centre, King's College London

London, UK

Dr Michael Kelleher

Consultant Addictions Psychiatrist, South London and Maudsley NHS Foundation Trust

London, UK

Arun Bhaskar

Charing Cross Hospital, Imperial College Healthcare NHS Trust

London, UK

Mat Southwell

European Network of People who Use Drugs (EuroNPUD)

Bath, UK

Professor Gabriele Fischer

Addictions Clinic Medical Director, Medical University of Vienna

Vienna, Austria

Dr Jane Quinlan

Oxford University Hospitals Trust

Oxford, UK

Dr Jeremy Hayllar

Clinical Director, Alcohol and Drug Service, Metro North Mental Health


Catriona Matheson

Professor in Substance Use, Stirling University


Dr Stephan Walcher

Director, Concept Centre for Addiction Medicine

Munich, Germany

Nicholas Lintzeris

Drug and Alcohol Services, South-East Sydney Local Health District

Sydney, Australia

Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire (NHSL)

Glasgow, Scotland

Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Professor Heino Stöver

Frankfurt University of Applied Sciences, Germany

Ashley Brown

Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London

London, UK


The 2020 IOTOD conference is supported by the following companies:


Gilead Sciences


Session Sponsors



Manoeuvres in the fog: drug-drug interactions in OST
Practicalities of transitioning between opioid agonist treatments
New horizons for treatment: translating the latest research into clinical practice
Tailoring behavioural interventions: emerging evidence and practical implications
View all webcasts